Bausch + Lomb Corporation (BLCO) Dividend History

Company News

• Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities

  The retinal and fundus camera market is experiencing growth driven by the evolving landscape of imaging technologies, particularly in diagnosing age-related macular degeneration (AMD). The integration of artificial intelligence (AI) into fundus cameras presents a significant opportunity for market growth, with AI algorithms demonstrating high accuracy in detecting diseases like diabetic retinopathy (DR).

  GlobeNewswire Inc.

  Featured Companies: BMEA EYEN OTLK
• Deal Dispatch: PharmChem Forgoes Banker To Run Sale, TGI Fridays Sells 19 Restaurants For $3.1 Million

  PharmChem is exploring strategic alternatives without a banker, while several other companies are involved in M&A deals, including Altus Power, Baxter International, Bausch & Lomb, KKR, and SolarWinds.

  Benzinga

  Featured Companies: BAX KKR
• Why Bausch + Lomb Stock Soared by Over 7% on Monday

  Bausch + Lomb, the eye care specialist, is reportedly exploring a sale, with large U.S. investment companies Blackstone and TPG showing interest in making a buyout bid. The company has also recently received FDA approval for its enVista Envy vision intraocular lenses.

  The Motley Fool

  Featured Companies: BX TPG
• Bausch + Lomb (BLCO) Reports Q2 Earnings: What Key Metrics Have to Say

  Bausch + Lomb reported $1.22 billion in revenue for Q2 2024, a 17.5% year-over-year increase. EPS was $0.13, down from $0.18 a year ago. The company's performance was mixed, with some business segments exceeding expectations while others fell short.

  Zacks Investment Research
• Tracking Carl Icahn's 13F Report - Q4 2023 Update

  This article provides an ongoing analysis of the changes made to Carl Icahn's 13F portfolio on a quarterly basis. Read more to see the Q4 2023 update.

  Seeking Alpha

  Featured Companies: AEP BHC CCK CNDT CVI D DAN IEP IFF ILMN NWL OXY SD SWX UAN